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Abstract  A  39-year-old  woman  underwent  uneventful  percutaneous  occlusion  of  an  ostium
secundum  atrial  septal  defect  (ASD)  with  a  22  mm  Ultrasept  ASD  Occluder
®
.  Transesophageal
echocardiography  (TEE)  performed  two  years  after  implantation  revealed  a  de novo  residual
left-to-right  shunt  through  the  correctly  implanted  device.  Three-dimensional  transesophageal
echocardiography  (3D  TEE)  further  clariﬁed  this ﬁnding  by  showing  a  perforation  of  the  device
membrane  coating.  The  patient  underwent  transcatheter  closure  of  the residual  shunt  with  a
20 mm  Ultrasept  PFO
®
device.  The  procedure  was  guided  by  ﬂuoroscopy  and  real-time  3D  TEE.
At the  end  of  the  procedure  3D TEE  documented  correct  device  deployment  with  complete
defect coverage  and  absence  of residual  shunt.
© 2017  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  All  rights
reserved.
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interauricular;
Shunt  residual;
Intervenc¸ão
percutânea
Encerramento  percutâneo  de comunicac¸ão  interauricular  residual  por falência
de  dispositivo
Resumo  Doente  de  39  anos,  género  feminino,  foi submetida  com  sucesso  a  encerramento
percutâneo  de  comunicac¸ão  interauricular  do  tipo  ostium  secundum  com  dispositivo  Ultrasept
Atrial Septal  Defect  Occluder
®
de  22  mm.  O  ecocardiograma  transesofágico,  realizado  dois
anos após  implantac¸ão,  revelou  shunt  esquerdo-direito  residual  de novo  através  do dispositivo
corretamente  implantado.  O  ecocardiograma  transesofágico  tridimensional  (ETE3D)  objetivou
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uma  perfurac¸ão  do  revestimento  do  dispositivo.  A  doente  foi  submetida  a  encerramento  per-
cutâneo  do  shunt  residual  com  dispositivo  UltraSept  PFO  Occluder
®
de  20  mm.  O  procedimento
foi guiado  por  ﬂuoroscopia  e ETE3D.  No  ﬁnal  do procedimento  por  ETE3D,  foi documentado  o
correto  posicionamento  do  dispositivo,  com  completa  cobertura  da  perfurac¸ão  e ausência  de
shunt residual.
©  2017  Sociedade  Portuguesa  de Cardiologia.  Publicado  por Elsevier  Espan˜a,  S.L.U.  Todos  os
direitos reservados.
Case  report
A  39-year-old  woman  presented  for  percutaneous  closure
of  an  ostium  secundum  atrial  septal  defect  (ASD)  with  a
balloon-sized  diameter  of  21  mm,  which  was  performed  suc-
cessfully  using  a  22  mm  Ultrasept  ASD  Occluder
®
(Cardia,
Eagan,  MN,  USA)  with  no  complications,  under  ﬂuoroscopic
and  transesophageal  echocardiography  (TEE)  guidance.  The
day  after  the  procedure,  transthoracic  echocardiography
(TTE)  showed  a  correctly  placed  device with  no  resid-
ual  shunt.  Two  years  after  the procedure,  TTE  followed
by  TEE  revealed  a residual  left-to-right  shunt through  the
correctly  implanted  device.  Three-dimensional  (3D)  TEE
enabled  more  detailed  characterization,  showing  a  perfo-
ration  of  the membrane  coating  0.09  cm2 in  area  on  the
inferior  portion  of  the  device  (Figure  1A  and  D).  Although
there  were  no  obvious  signs of  right  ventricular  overload,
Figure  1  (A  and  D)  Three-  (3D TEE)  and two-dimensional  transesophageal  echocardiography  images  showing  residual  shunt  through
the device  (22  mm  Ultrasept  ASD  Occluder
®
);  (B  and  C)  delivery  sheath  through  the Ultrasept  device  in ﬂuoroscopic  view  and  in 3D
TEE; (E  and  F)  closure  of  residual  shunt  in  the  22  mm  Ultrasept  device  with  a  20  mm  Ultrasept  PFO  device,  with  the  ﬁnal result
documented  in  ﬂuoroscopic  view  and  in 3D  TEE.
the  patient  complained  of  fatigue  on  minimal  exertion  and
occasional  chest  discomfort.
She  accordingly  underwent  a second  cardiac  catheter-
ization  for  hemodynamic  measurement  and  possible
transcatheter  closure  of  the  residual  shunt.  The  procedure
was  performed  under  general  anesthesia,  guided  by  ﬂuo-
roscopy  and real-time  3D  TEE  (Figure  1B,  C,  E and  F).  The
Qp:Qs  obtained  by  catheterization  was  1.7  and therefore  we
decided  to  proceed  with  implantation  of  a second  device.  We
chose  a  20  mm  Ultrasept  PFO  occluder  with  the expectation
that  a  similar  device would  conform  better  to  the  previously
implanted  occluder.
The  device  defect  was  crossed  with  a  combination  of  a 6 F
right  Judkins  diagnostic  catheter  (Boston  Scientiﬁc,  Natick,
MA)  and  a  standard  0.35′′ ZIPwireTM Hydrophilic  Guide  Wire
(Boston  Scientiﬁc,  Natick,  MA) placed  in  the left  superior
pulmonary  vein.  We  opted  not to  perform  balloon  sizing;
Document downloaded from http://www.elsevier.es, day 16/10/2017. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Successful  percutaneous  closure  of  a residual  atrial  septal  defect  475.e3
otherwise  the  interventional  procedure  was  performed  with
the  standard  ASD  closure technique,  taking  extra  care  with
the  9 F  delivery  sheath  to  avoid  displacement  of  the device
already  in  place.
During  the  procedure,  3D  TEE  was  of  crucial  importance
in  guiding  the  position  of  guidewires  and  sheaths,  delivery
and  spatial  relations  between  devices.
The  procedure  took  60  min  with  a total  radiation  time  of
14  min  and  total  radiation  dose of  865 mGy  (8101  cGy.cm2).
At  the  end  of  the procedure  3D  TEE  documented  cor-
rect  device  placement  with  complete  defect  coverage  and
absence  of  residual  shunt.
Discussion
The  Ultrasept  ASD  device  is  covered  by a  polyvinyl  alcohol
(PVA)  membrane.  PVA  is  a  bioabsorbable  elastomeric  poly-
mer  with  good biocompatibility  that  is  commonly  used  in
medical  devices  due  to  its low protein  adsorption,  absence
of  toxicity  and bioadhesive  characteristics.  Although  the
use  of  this  material  in ASD  closure  devices  is  generally
successful,  a  few  cases  of  PVA  membrane  perforation  and
recanalization  have  been  described  recently.1,2 According
to  company  data  only 10  cases  have  been  reported,  all  of
them  with  ASD  occluders  and  none  with  PFO  closure  devices.
The  mechanism  by  which  the PVA  coating  degrades  is  not
completely  understood,  but  is  likely  related  to  incomplete
endothelialization  due  to  delayed  or  inadequate  endothe-
lial  response.3 This  phenomenon  has  been reported  in a few
patients  with  other  ASD  devices,  such as  the AmplatzerTM
family,  supporting  the hypothesis  of an  absent  or  inadequate
endothelization  response  in speciﬁc patients,  of  unknown
cause.3,4 In  our  patient,  there  was  no evidence  of  an early
residual  shunt,  but  we  cannot  speculate  on  the  speciﬁc
causes  that  may have given rise  to  this  mid-term  residual
ASD.
We  adopted  a  percutaneous  approach  guided  by  real-time
3D  TEE,  which  offered  precise  spatial  location  of  the per-
foration  and  orientation  of  sheaths  and devices.  A 20  mm
Ultrasept  PFO  occluder  was  chosen  because  (a)  it appeared
to  be  the  most  easily  adjustable  for the  small but  asymmet-
ric  hole,  (b)  no  residual  holes  have  been  reported  in these
devices,  (c)  we  thought  that  it would be  better  to  juxtapose
two  devices  with  the  same  type  of  frame,  and  (d)  it has  a
low proﬁle,  resulting  in a small  increase  in thickness  and
no  compression  of  surrounding  structures,  particularly  the
aortic  wall.
This  case  highlights  the  importance  of close  follow-up  in
all  patients  with  ASD  treated  with  implanted  devices.  There
should  be a  low  threshold  for  TEE in  the event  of any  sus-
picious  ﬁndings  on  TTE  or  changes  in the  patient’s  clinical
status.  Our  case  demonstrates  a new  and  successful  way
of  correcting  ASD  device perforations  with  a percutaneous
approach  that avoids  the need  for  surgical  intervention.
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